Breakthrough in Alzheimer's Disease: AFFiRiS Halted Clinical Progression in Alzheimer Patients Upon Treatment With AD04 in a Phase II Clinical Study - MarketWatch

Breakthrough in Alzheimer's Disease: AFFiRiS Halted Clinical Progression in Alzheimer Patients Upon Treatment With AD04 in a Phase II Clinical Study - MarketWatch: AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients. Upon treatment with AD04, effects consistent with disease modification were achieved for at least 18 months in 47% of treated patients. This beneficial effect was dose dependent and more effective in early disease patients. Furthermore, prevention of hippocampal decline was correlated with the beneficial impact on clinical progression and was statistically significant. Therefore, these results for the very first time meet all of the criteria for disease modification as defined by US and European Regulatory Agencies FDA (Food and Drug administration) and EMA (European Medicines Agency).

A Word from Dr. Pfenninger: Seven risk factors for Alzheimer's disease

A Word from Dr. Pfenninger: Seven risk factors for Alzheimer's disease: Each time something like this happens to us, especially as we add on a few years in our life, the thought remotely crosses through our minds that perhaps we are getting Alzheimer’s disease (AD). Okay, so maybe it doesn’t happen all the time, but in a busy, active life there are many decisions made every day and things need to be remembered that we forget. When we can’t remember all 102 items, we become concerned.

foodconsumer.org - Nutrition and the Risk of Alzheimer's Disease

foodconsumer.org - Nutrition and the Risk of Alzheimer's Disease

Distrusting and Cynical? You May be Hurting Your Brain: Dementia Linked to Cynical Distrust

Distrusting and Cynical? You May be Hurting Your Brain: Dementia Linked to Cynical Distrust: Cynical distrust is defined as the belief that others are mainly motivated by selfish concerns. It's actually been associated with other health problems in the past, such as heart disease. That's why scientists decided to take a closer look at cynical distrust and see how else it might impact an individual.

Are You a Cynic? The Unexpected Way It Could Affect Your Health | TheBlaze.com

Are You a Cynic? The Unexpected Way It Could Affect Your Health | TheBlaze.com: The study, published the American Academy of Neurology’s journal “Neurology,” is the first to examine the relationship between cynical distrust, a belief that others are motivated by selfish concerns, and dementia. Previous research has looked at the link between such an attitude and other health issues.

Workplace Solvents Linked to Long-Term Memory, Thinking Problems – WebMD

Workplace Solvents Linked to Long-Term Memory, Thinking Problems – WebMD: A new study of French power company retirees finds that those who were exposed to solvents and benzene on the job -- even decades earlier -- were more likely to score poorly on memory and thinking tests.

The findings don't directly confirm that the chemicals harmed the mental powers of the former workers, and it was not clear if those with more thinking problems face more issues getting through their day-to-day lives.

Common antidepressant may halt plaque growth associated with Alzheimer’s | Fox News

Common antidepressant may halt plaque growth associated with Alzheimer’s | Fox News: New research published in the journal Science Translational Medicine reveals that the frequently prescribed antidepressant citalopram, also known as Celexa, could play a role in halting the progression of the brain-wasting disease.






ADVERTISEMENT





Antidepressants like citalopram offer hope by targeting the brain’s amyloid beta proteins, which seem to be responsible for triggering the plaque build-up associated with the decline of memory and cognitive function in Alzheimer’s patients.

Alzheimer's disease could be as much about lifestyle as aging : Wsj

Alzheimer's disease could be as much about lifestyle as aging : Wsj: Obesity, smoking, stress and other factors may have as much to do with getting Alzheimer’s as aging does, said Dr. Mark Sager, longtime director of WRAP until he retired last month.

“What we view as a disease of old age is actually a disease of lifestyle and environment to some extent,” Sager said.

A University of California-San Francisco study in 2011 found that seven factors — diabetes, high blood pressure, obesity, smoking, depression, physical inactivity and low educational attainment — contribute to up to half of Alzheimer’s cases.

The seven stages of Alzheimer’s disease progression - Thegardenisland.com: Opinion

The seven stages of Alzheimer’s disease progression - Thegardenisland.com: Opinion: In the early stages of Alzheimer’s disease there is no memory loss and a medical professional would not note any dementia. In the second stage of the disease, the individual may feel that they are having memory issues. They may forget familiar words or where they put something, but a medical examination would not reveal anything, and family and acquaintances would not notice any signs of dementia.

Dad With Alzheimer's Gets His Speech Back When He Sees His Dog

Dad With Alzheimer's Gets His Speech Back When He Sees His Dog: Late-stage Alzheimer's disease can be a cruel and brutal thing, as the loss of vocabulary gives way to the inability to speak at all. That's the situation Lisa Abeyta's father finds himself in most days, but there's one thing that seems to help: the family dog.

Abeyta caught this video of her dad getting his speech back for a rare moment, to tell the dog, "Why don't I take care? I'll take you, and you take me."